Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries.

Burn E., Li X., Kostka K., Stewart HM., Reich C., Seager S., Duarte-Salles T., Fernandez-Bertolin S., Aragón M., Reyes C., Martinez-Hernandez E., Marti E., Delmestri A., Verhamme K., Rijnbeek P., Horban S., Morales DR., Prieto-Alhambra D.

DOI

10.1002/pds.5419

Type

Journal article

Publication Date

2022-05-01T00:00:00+00:00

Volume

31

Pages

495 - 510

Total pages

15

Keywords

Covid-19, post vaccine, thrombosis-thrombocytopenia syndromes (TTS), vaccine, COVID-19, COVID-19 Vaccines, Humans, Incidence, Syndrome, Thrombocytopenia, Thrombosis

Permalink More information Close